谷歌浏览器插件
订阅小程序
在清言上使用

Long-term Follow Up of Selinexor Maintenance in Patients with TP53wt Advanced or Recurrent Endometrial Cancer: A Pre-Specified Subgroup Analysis from the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2023)

引用 0|浏览28
暂无评分
关键词
Cancer Therapy,Tumor Suppression,p53
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要